Albireo Pharma Overview

Albireo Pharma Selling, General & Admin

Selling, General & Admin expenses for ALBO.

Quarterly SG&A Expenses

$20.56M

↑ 16.76% YoY

As of Sep 30, 2022

Annual SG&A Expenses (TTM)

$78.76M

↑ 23.1% YoY

Trailing 12 months ending Sep 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin